Average Co-Inventor Count = 8.25
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (10 from 4,179 patents)
2. Rempex Pharmaceuticals, Inc. (8 from 27 patents)
3. Janssen Pharmaceutica Nv (4 from 2,079 patents)
4. Abbott Gmbh & Co Kg (4 from 140 patents)
5. Melinta Subsidiary Corp. (3 from 13 patents)
6. Sgx Pharmaceuticals, Inc. (2 from 17 patents)
7. Abbvie Inc. (1 from 822 patents)
8. Endosome Therapeutics, Inc. (1 from 1 patent)
9. Melinta Therapeutics, Inc. (24 patents)
10. Abbvie Bahamas Limited (6 patents)
33 patents:
1. 12516038 - Inhibitors of antigen presentation by HLA-DR
2. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
3. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
4. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
5. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
6. 11324832 - Tripartite modulators of endosomal G protein-coupled receptors
7. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
8. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
9. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
10. 10183034 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
11. 10172874 - Pharmaceutical compositions comprising cyclic boronic acid ester derivatives
12. 10004758 - Cyclic boronic acid ester derivatives and methods of making the same
13. 9694025 - Cyclic boronic acid ester derivatives and therapeutic uses thereof
14. 9296763 - Cyclic boronic acid ester derivatives and therapeutic uses thereof
15. 8680136 - Cyclic boronic acid ester derivatives and therapeutic uses thereof